Home › Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin...
 

Keywords :   


Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin...

2013-04-17 10:47:14| Chemicals - Topix.net

Bayer HealthCare Pharmaceuticals Inc. announced today that patient enrollment is underway in its global Phase III trial program to evaluate the efficacy and safety of adjunctive aerosolized BAY41-6551 versus aerosolized placebo in the treatment of intubated and mechanically ventilated patients with Gram-negative pneumonia receiving standard of care ... (more)

Tags: iii trial phase bayer

Category:Chemicals

Latest from this category

All news
23.11Weekly Recap: PPG, John Morikis, Sika Top This Weeks Stories
22.11Andrea Wagner Watts to Deliver Keynote Address at ACAs 2025 CoatingsTech Conference
22.11Hempels Infinity Silicone Hull Paint Recharger Launched for Yachts
22.11The Lehigh 56th Annual Short Course Website is Open
21.11allnex Announces Strategic Investment in East St. Louis Site
21.11Syensqo Expands Polymer Production Capacity
21.11¦nie¿ka Publishes Results for Three Quarters of 2024
21.11Sheboygan Paint Company Names New Customer Service Manager
Chemicals »
24.11ISAMI REBELS16oz
24.11 Z
24.11
24.11 4 trail lite
24.11n-buna song selection
24.11()//
24.11MTG 4
24.11 Jade Flufy Crew Sweat
More »